Product Information

DOXEPIN HCL 3 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3614 per EA under NDC 59651084430. Its NADAC has been published 36 times since Oct 22, 2025.

DOXEPIN HCL 3 MG TABLET

DOXEPIN
$1.3614per EA

Strength

3 mg/1

NDC

59651084430

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216041

On Market Since

7/12/2025

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN HCL 3 MG TABLET has been published 36 times since Oct 22, 2025, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3614 per EA
All-time high$2.1099 (Nov 12, 2025)
All-time low$1.3614 (Jun 17, 2026)
52-week high$2.1099
52-week low$1.3614
Median price$1.5930
Average price$1.7619
Largest weekly change-16.0% (Jan 21, 2026)
Weeks tracked36
Tracking sinceOct 22, 2025

Price History

1W

0.0%

1M

-9.7%

3M

-14.2%

6M

-34.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-35.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DOXEPIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DOXEPIN HCL 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.3614 per EA (NDC 59651084430), effective Jun 24, 2026.

How has the price of DOXEPIN HCL 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 35.5%. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.

What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?

Since Oct 22, 2025, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3614 (Jun 17, 2026) to a high of $2.1099 (Nov 12, 2025), with a median of $1.5930 per EA.

Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOXEPIN HCL 3 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures DOXEPIN HCL 3 MG TABLET?

DOXEPIN HCL 3 MG TABLET (NDC 59651084430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.